Your browser doesn't support javascript.
loading
Circulating CXCL13 could be serving as a biomarker for chronic lymphocytic leukemia severity.
Aref, Salah; Atia, Doaa; Ramez, Ahmed; Zeid, Tarek Abou; Gouda, Enas.
Afiliação
  • Aref S; Hematology Unit, Clinical Pathology Department, Mansoura University, Mansoura, Egypt.
  • Atia D; Hematology Unit, Clinical Pathology Department, Mansoura University, Mansoura, Egypt.
  • Ramez A; Medical Oncology Unit, Mansoura University Oncology Center, Mansoura, Egypt.
  • Zeid TA; Hematology Unit, Internal Medicine Department, Mansoura University Oncology Center, Mansoura University, Mansoura, Egypt.
  • Gouda E; Hematology Unit, Clinical Pathology Department, Mansoura University, Mansoura, Egypt.
Cancer Biomark ; 34(1): 105-111, 2022.
Article em En | MEDLINE | ID: mdl-34719478
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Idioma: En Ano de publicação: 2022 Tipo de documento: Article